Condition: Advanced Esophagus Cancer
Intervention: Drug: Apatinib
Sponsors: Henan Cancer Hospital; Jiangsu HengRui Medicine Co., Ltd.
Recruiting - verified May 2017
from #ORL via a.lsfakia on Inoreader http://ift.tt/2rljCSF
via IFTTT
http://ift.tt/2qCmAF0
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma Recent Results Cancer Res. Authors: Raue F, Frank-Raue K Abstrac...
-
Publication date: Available online 10 April 2017 Source: British Journal of Oral and Maxillofacial Surgery Author(s): V. Ramieri, V. Vello...
-
Abstract Background Intracranial hemorrhage is a rare but potentially severe complication of spinal surgery. Most reported post-operativ...
-
EDITORIAL Pediatric retina: A challenging yet fascinating field p. 179 Wei-Chi Wu DOI :10.4103/tjo.tjo_123_18 [HTML Full text] [PDF] ...
-
Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight. Int J Pharm. 2016 Aug 16;...
-
Abstract Purpose The present study aimed to determine the level of physical activity (PA) among prostate cancer (PCa) patients across tr...
-
Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182, alsfakia@gmail.com http://ift.tt/...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου